Vertex Pharmaceuticals | Attività Correnti

Current Assets Cambiamento Data
Acadia Pharmaceuticals USD 616.12M 116.96M 2023-12
Agios Pharmaceuticals USD 833.83M 129.48M 2023-12
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Amgen USD 30.33B 18.14B 2023-12
Arrowhead Research USD 237.9M 181.62M 2023-12
Gilead Sciences USD 16.45B 474M 2023-12
Incyte USD 4.65B 242.74M 2023-12
Insmed USD 929.06M 2.49M 2023-12
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Moderna USD 10.32B 474M 2023-12
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
Pfizer USD 74.01B 665M 2023-09
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Roche Holding CHF 30.98B 2.84B 2023-06
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
United Therapeutics USD 3.55B 92.1M 2023-12
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09



Vertex Pharmaceuticals Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.